Real-time TaqMan PCR as a specific and more sensitive alternative to the branched-chain DNA assay for quantitation of simian immunodeficiency virus RNA

AIDS Research and Human Retroviruses

Volumn 17, Issue 3, 2001, Pages 243-251

  Leutenegger, C M ^a   Higgins, J ^a   Matthews, T B ^a   Tarantal, A F ^a   Luciw, P A ^a   Pedersen, N C ^a   North, T W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; GENE AMPLIFICATION; INTERMETHOD COMPARISON; MONKEY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; REPRODUCIBILITY; RNA ANALYSIS; SIMIAN IMMUNODEFICIENCY VIRUS; STRAIN DIFFERENCE;

ANIMALS; BRANCHED DNA SIGNAL AMPLIFICATION ASSAY; DNA, VIRAL; HIV; HIV INFECTIONS; HUMANS; MACACA MULATTA; POLYMERASE CHAIN REACTION; REAGENT KITS, DIAGNOSTIC; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; TAQ POLYMERASE;

EID: 0035835505     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922201750063160     Document Type: Article

References (43)

1. The AIDS epidemic - Considerations for the 21st century
2. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy
3. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less
4. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma
5. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection
6. Identification of a reservoir for HIV-1 in patients on highly active antiretrovirai therapy
7. Use of real-time PCR and molecular beacons to detect virus replication in human immunodeficiency virus type 1-infected individuals on prolonged effective antiretroviral therapy
8. HIV-1 replication in patients with undetectable plasma virus receiving HAART. Highly active antiretroviral therapy
9. Residual HIV-RNA levels persist for up to 2.5 years in peripheral blood mononuclear cells of patients on potent antiretroviral therapy
10. A stable latent reservoir for HIV-1 in resting CD4+ T lymphocytes in infected children
11. Detection of infectious HIV in circulating monocytes from patients on prolonged highly active antiretroviral therapy
12. Early establishment of a pool of latently infected, resting CD4+ T cells during primary HIV-1 infection
13. Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy
14. Containment of simian immunodeficiency virus infection: Cellular immune responses and protection from rechallenge following transient postinoculation antiretroviral treatment
15. Antiretroviral therapy during primary immunodeficiency virus infection can induce persistent suppression of virus load and protection from heterologous challenge in rhesus macaques
16. The simian immunodeficiency viruses
17. Immediate zidovudine treatment protects simian immunodeficiency virus-infected newborn macaques against rapid onset of AIDS
18. Simian immunodeficiency virus (SIV) infection of infant rhesus macaques as a model to test antiretroviml drug prophylaxis and therapy: Oral 3′-azido-3′-deoxythymidine prevents SIV infection
19. Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine
20. Efficacy of 9-(2-phosphonylmethoxyethyl)adenine treatment against chronic simian immunodeficiency virus infection in macaques
21. Sensitivity/resistance profile of a simian immunodeficiency virus containing the reverse transcriptase gene of human immunodeficiency virus type 1 (HIV-1) toward the HIV-1-specific non-nucleoside reverse transcriptase inhibitors
22. Quantitative and cost comparison of ultrasensitive human immunodeficiency virus type 1 RNA viral load assays: Bayer bDNA quantiplex versions 3.0 and 2.0 and Roche PCR Amplicor monitor version 1.5
23. A genetic and viral load analysis of the simian immunodeficiency virus during the acute phase in macaques inoculated by the vaginal route
24. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene
25. Characterization of infectious molecular clones of simian immunodeficiency virus (SIVmac) and human immunodeficiency virus type 2: Persistent infection of rhesus monkeys with molecularly cloned SIVmac
26. Simian-human immunodeficiency virus containing an human immunodeficiency virus type 1 subtype-E envelope gene: Persistent infection CD4+ T-cell depletion, and mucosal membrane transmission in macaques
27. Mutations at codon 184 in simian immunodeficiency virus reverse transcriptase confer resistance to the (-) enantiomer of 2′,3′-dideoxy-3′-thiacytidine
28. Rhesus macaques inoculated with molecularly cloned simian immunodeficiency virus
29. Identification of viral determinants of macrophage tropism for simian immunodeficiency virus SIVmac
30. Vaccine protection by a triple deletion mutant of simian immunodeficiency virus
31. The intracytoplasmic domain of the Env transmembrane protein is a locus for attenuation of simian immunodeficiency virus SIVmac in rhesus macaques
32. Plasma SIV RNA viral load determination by real-time quantification of product generation in reverse transcriptase-polymerase chain reaction
33. Rapid feline immunodeficiency virus provirus quantitation by polymerase chain reaction using the TaqMan fluorogenic real-time detection system
34. Sensitive and robust one-tube real-time reverse transcriptase-polymerase chain reaction to quantify SIV RNA load: Comparison of one- versus two-enzyme systems
35. Evaluation of the ultrasensitive Roche Amplicor HIV-1 monitor assay for quantitation of human immunodeficiency virus type 1 RNA
36. Molecular evolution of the human and simian immunodeficiency viruses
37. Proviral load determination of different feline immunodeficiency virus isolates using real-time polymerase chain reaction: Influence of mismatches on quantification
38. A pathogenic threshold of virus load defined in simian immunodeficiency virus- or simian-human immunodeficiency virus-infected macaques
39. The extent of early viral replication is a critical determinant of the natural history of simian immunodeficiency virus infection
40. Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection
41. Plasma viremia in macaques infected with simian immunodeficiency virus: Plasma viral load early in infection predicts survival
42. Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: Effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara
43. Quantitative evaluation of simian immunodeficiency virus infection using NASBA technology